Dr. Ortiz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 Branch St
Ste 100
Methuen, MA 01844Phone+1 978-620-2020Fax+1 978-620-2299
Summary
- Dr. Taylor Ortiz is an oncologist in Indianapolis, IN and is affiliated with multiple hospitals in the area, including Franciscan Health Indianapolis, and Franciscan Health Lafayette East. He received his medical degree from Harvard Medical School and his Medical Oncology and Hematology training at the Dana-Farber Cancer Institute and Massachusetts General Hospital. He has been in practice 13 years. He is experienced in solid tumor oncology, hematologic oncology, with executive leadership experience including program development, recruiting, clinical informatics, and phase 2/3 clinical trials.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2007 - 2010
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2004 - 2007
- Harvard Medical SchoolClass of 2004
Certifications & Licensure
- NH State Medical License 2010 - Present
- IN State Medical License 2015 - 2025
- MA State Medical License 2007 - 2025
- IL State Medical License 2004 - 2007
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- American Board of Preventive Medicine Clinical Informatics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Clinical Trials
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
- Join now to see all
Publications & Presentations
PubMed
- 89 citationsThe Introduction of Systematic Genomic Testing for Patients With Non-Small-Cell Lung CancerStephanie Cardarella, Taylor M. Ortiz, Victoria A. Joshi, Mohit Butaney, David M. Jackman
Journal of Thoracic Oncology. 2012-12-01 - 63 citationsG-CSF is not necessary to maintain over 99% dose–intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysisAndrew M. Evens, Jeffrey Cilley, Taylor Ortiz, Mrinal M. Gounder, Nanjiang Hou
British Journal of Haematology. 2007-06-01 - 11 citationsCD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome.Stefan Heinrichs, Jason N. Berman, Taylor M. Ortiz, Steven M. Kornblau, Donna Neuberg
British Journal of Haematology. 2005-07-01
Press Mentions
- Franciscan Health Lafayette to Break Ground on Cancer CenterJune 29th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: